Login / Signup

Computational screening of FDA approved drugs of fungal origin that may interfere with SARS-CoV-2 spike protein activation, viral RNA replication, and post-translational modification: a multiple target approach.

Rajveer SinghAnupam GautamShivani ChandelVipul SharmaArijit GhoshDhritiman DeySyamal RoyV RavichandiranDipanjan Ghosh
Published in: In silico pharmacology (2021)
The online version contains supplementary material available at 10.1007/s40203-021-00089-8.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • social media
  • health information
  • psychometric properties
  • drug administration
  • protein protein
  • amino acid
  • binding protein
  • small molecule